×
ADVERTISEMENT

eosinophilic esophagitis

FDA Approves Dupixent for Pediatric Eosinophilic Esophagitis

The FDA approved Dupixent to treat eosinophilic esophagitis in children ages 1 year and older. 

JANUARY 26, 2024

FDA Expands Dupilumab Indication to EoE

Dupilumab is now indicated for the treatment eosinophilic esophagitis in patients 12 years and older weighing more ...

MAY 23, 2022

Load more